Delivery Order SPE2DR25D3108-SPE2DR26F1PVS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,334.50 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count). This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of September 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Contrave is an FDA-approved pharmaceutical product used for weight...
- The Defense Logistics Agency awarded a delivery order valued at $1,563.72 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count), with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,391.13 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count unit). This is a firm fixed-price, non-set-aside contract with a completion date of July 29, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,515.09 delivery order for Contrave ER 8-90 mg tablets (120-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.90 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Contrave ER 8-90 mg tablets (120-unit quantity). This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,406.51 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on August 1, 2025, with completion targeted for August 4, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,621.15 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $5,214.68 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units). This is a firm fixed-price, non-competitive award with an ultimate completion date of September 23, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters. As a child contract, this delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units) valued at $4,174.92. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 4, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading...
- The Defense Logistics Agency awarded a $11,604.01 delivery order to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120-count supply) on October 22, 2025, with completion scheduled for October 23, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 vehicle...
- SPE2DR25D3108Indefinite Delivery Contract
- SPE2DR25D3108-SPE2DR26F1PVSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,654.69 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120-count supply), with a firm fixed price structure and an ultimate completion date of December 15, 2025. This non-set-aside, competitively awarded contract was issued on December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive federal contract portfolio encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for Contrave, an obesity management medication, represents one of numerous pharmaceutical transactions the contractor executes under its prime IDC with DLA, demonstrating the company's established capability to supply medical products supporting Department of Defense healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 12/11/25 |